These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1415474)

  • 21. [Cerebral amyloidosis: Alzheimer's disease and amyloid degeneration].
    Hirai S
    No To Shinkei; 1994 May; 46(5):455-62. PubMed ID: 8060684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebral amyloid angiopathy in Alzheimer's disease: with special reference to its incidence and distribution].
    Ando S; Nakayama H
    No To Shinkei; 1984 Nov; 36(11):1109-16. PubMed ID: 6525324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition.
    Tuszynski MH; Smith DE; Roberts J; McKay H; Mufson E
    Exp Neurol; 1998 Dec; 154(2):573-82. PubMed ID: 9878192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alzheimer's disease, amyloidosis, microglia and astrocytes].
    Hauw JJ; Duyckaerts C; Delaere P; Chaunu MP
    Rev Neurol (Paris); 1988; 144(3):155-7. PubMed ID: 3285438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
    More SS; Vince R
    ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anesthetics promoting in vitro AβPP metabolism and amyloid-β toxicity.
    Eckel B; Blobner M; Rammes G
    J Alzheimers Dis; 2010; 22 Suppl 3():21-6. PubMed ID: 20858965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease.
    Faure A; Verret L; Bozon B; El Tannir El Tayara N; Ly M; Kober F; Dhenain M; Rampon C; Delatour B
    Neurobiol Aging; 2011 Mar; 32(3):407-18. PubMed ID: 19398247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-beta precursor protein processing in neurodegeneration.
    Wilquet V; De Strooper B
    Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
    Glenner GG; Wong CW; Quaranta V; Eanes ED
    Appl Pathol; 1984; 2(6):357-69. PubMed ID: 6242724
    [No Abstract]   [Full Text] [Related]  

  • 35. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA; Herzig MC; Coomaraswamy J; Kilger E; Selenica ML; Winkler DT; Staufenbiel M; Levy E; Grubb A; Jucker M
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
    Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
    J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease. Amyloid precursor on the G(o).
    Hanley MR; Selkoe DJ
    Nature; 1993 Mar; 362(6415):14-5. PubMed ID: 8383293
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of amyloidosis.
    Kisilevsky R; Young ID
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):613-26. PubMed ID: 7954865
    [No Abstract]   [Full Text] [Related]  

  • 39. A beta amyloidogenesis: unique, or variation on a systemic theme?
    Kisilevsky R; Fraser PE
    Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, Turkey.
    Geula C; Emre M; Friedland RP
    Amyloid; 2004 Dec; 11(4):276-80. PubMed ID: 15678765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.